Complications Associated With Posterior and Transforaminal Lumbar Interbody Fusion

被引:69
作者
Chrastil, Jesse [1 ]
Patel, Alpesh A. [2 ]
机构
[1] Univ Utah, Dept Orthopaed, Salt Lake City, UT 84112 USA
[2] Loyola Univ, Dept Orthopaed Surg, Chicago, IL 60611 USA
关键词
BONE MORPHOGENETIC PROTEIN-2; OFF-LABEL USE; SURGICAL-TREATMENT; SPINAL SURGERY; RHBMP-2; CAGES; MANAGEMENT; INFECTION; MIGRATION; SAFETY;
D O I
10.5435/JAAOS-20-05-283
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Posterior lumbar interbody fusion and transforaminal lumbar interbody fusion are commonly performed to obtain a 360 degrees arthrodesis through a posterior-only approach. These techniques are currently used in the management of spondylolisthesis, degenerative scoliosis, pseudarthrosis, recurrent disk herniation, and chronic low back pain with associated degenerative disk disease. Several adverse events have been described, including intraoperative neurologic injury, implant migration or subsidence, dural tears, infection, heterotopic ossification, BMP-related radiculitis, and osteolysis. Although the use of newer materials (eg, bone morphogenetic proteins) and procedures (eg, minimally invasive surgery) is on the rise, they are associated with unique concerns. Understanding the potential adverse events and steps that can be taken to prevent, detect, and manage complications is critical in patient counseling and perioperative decision making.
引用
收藏
页码:283 / 291
页数:9
相关论文
共 40 条
[1]   Posterior Migration of Fusion Cages in Degenerative Lumbar Disease Treated With Transforaminal Lumbar Interbody Fusion A Report of Three Patients [J].
Aoki, Yasuchika ;
Yamagata, Masatsune ;
Nakajima, Fumitake ;
Ikeda, Yoshikazu ;
Takahashi, Kazuhisa .
SPINE, 2009, 34 (01) :E54-E58
[2]  
Briggs H, 1944, J BONE JOINT SURG, V26, P125
[3]   A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned [J].
Carragee, Eugene J. ;
Hurwitz, Eric L. ;
Weiner, Bradley K. .
SPINE JOURNAL, 2011, 11 (06) :471-491
[4]   Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion Report of 4 cases [J].
Chen, Nan-Fu ;
Smith, Zachary A. ;
Stiner, Eric ;
Armin, Sean ;
Sheikh, Hormoz ;
Khoo, Larry T. .
JOURNAL OF NEUROSURGERY-SPINE, 2010, 12 (01) :40-46
[5]   Surgical treatment of recurrent lumbar disc herniation by transforaminal lumbar interbody fusion [J].
Chen, Zhiming ;
Zhao, Jie ;
Liu, AiGang ;
Yuan, Jiandong ;
Li, Zhonghai .
INTERNATIONAL ORTHOPAEDICS, 2009, 33 (01) :197-201
[7]   Transforaminal Lumbar Interbody Fusion Versus Anterior Lumbar Interbody Fusion as an Adjunct to Posterior Instrumented Correction of Degenerative Lumbar Scoliosis [J].
Crandall, Dennis G. ;
Revella, Jan .
SPINE, 2009, 34 (20) :2126-2133
[8]   Outcomes after incidental durotomy during first-time lumbar discectomy [J].
Desai, Atman ;
Ball, Perry A. ;
Bekelis, Kimon ;
Lurie, Jon D. ;
Mirza, Sohail K. ;
Tosteson, Tor D. ;
Weinstein, James N. .
JOURNAL OF NEUROSURGERY-SPINE, 2011, 14 (05) :647-653
[9]   Clinical and radiographic comparison of mini-open transforaminal lumbar interbody fusion with open transforaminal lumbar interbody fusion in 42 patients with long-term follow-up [J].
Dhall, Sanjay S. ;
Wang, Michael Y. ;
Mummaneni, Praveen V. .
JOURNAL OF NEUROSURGERY-SPINE, 2008, 9 (06) :560-565
[10]   Bone morphogenetic protein-2 and spinal arthrodesis: the basic science perspective on protein interaction with the nervous system [J].
Dmitriev, Anton E. ;
Lehman, Ronald A., Jr. ;
Symes, Aviva J. .
SPINE JOURNAL, 2011, 11 (06) :500-505